Month: August 2024

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group

Written by Customer Service on August 7, 2024. Posted in Mergers And Acquisitions.

PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk Group will acquire all of the outstanding shares of PetIQ’s common stock for $31.00 per share, in an all-cash transaction valued at approximately $1.5 billion. PetIQ’s Board of Directors (the “Board”) has approved the Agreement, which represents a premium of approximately 41% to the 30-day volume-weighted average stock...

Conduent Reports Second Quarter 2024 Financial Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Key Q2 2024 HighlightsRevenue: $828M Adj. Revenue(1): $811M Pre-tax Income: $300M Adj. EBITDA Margin(1): 3.6% New Business Signings ACV(2): $142M Net ARR Activity Metric(2) (TTM): $(49)MFLORHAM PARK, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) — Conduent (NASDAQ: CNDT), a global technology-led business process solutions and services company, today announced its second quarter 2024 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “We are pleased to report that our Adjusted Revenue and Adjusted EBITDA exceeded expectations, with upside from here. Meanwhile, as anticipated, Q2 represented the low point in our previously communicated growth trajectory. Commercial sales were stronger on both a year-over-year and sequential basis and although Government sales is off to a slower than anticipated start...

MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development Update

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Conference Call to Begin Today at 9:00 a.m. (ET)2Q 2024 Total revenues of $72M; +49% vs. 2Q 2023 YTD 2024 Total revenues of $139M; +55% vs. YTD 2023 YTD 2024 Net income of $9 million; Non-GAAP net income of $29 million Advances two orphan lung programs to human studiesMNKD-101 Phase 3 clinical trial activities initiated MNKD-201 Phase 1 clinical trial on schedule to read out 4Q 2024DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today reported financial results for the quarter ended June 30, 2024. “We achieved our ninth consecutive quarter of revenue growth and are approaching an annual revenue run rate of over $275 million based on the first half of 2024,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “We are excited about...

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

— Reported positive topline data from pivotal Phase 3 BROOKLYN trial evaluating obicetrapib in patients with HeFH; achieved primary endpoint of LS mean reduction in LDL-C versus placebo, as well as statistically significant reductions in other biomarkers, with safety results comparable to placebo – — Extended US IP protection into 2043 with a new composition of matter patent — — On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – — Completed enrollment of pivotal Phase 3 TANDEM trial evaluating fixed-dose combination of obicetrapib and ezetimibe; topline data expected in 1Q 2025 — — Strong financial position; $430.7 million in cash — NAARDEN, the Netherlands and MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or...

Intermex Reports Second Quarter Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Company continues to generate strong earnings and margins, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), one of the nation’s leading omnichannel money transfer services to Latin America and the Caribbean, today reported strong operating results for the second quarter of 2024. Financial performance highlights for the second quarter of 2024 compared with the same period last year are:Revenues of $171.5 million, an increase of 1.4%. Net income of $14.0 million, a decrease of 9.1%. Diluted EPS of $0.42 per share, same as the prior period. Adjusted Diluted EPS of $0.55 per share, an increase of 10.0%. Adjusted EBITDA of $31.1 million, an increase of 0.6%.Bob Lisy,...

Stryker declares an $0.80 per share quarterly dividend

Written by Customer Service on August 7, 2024. Posted in Dividend Reports And Estimates.

Portage, Michigan, Aug. 07, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable October 31, 2024 to shareholders of record at the close of business on September 30, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com. Contacts For investor inquiries please contact:Jason...

Karat Packaging Board Declares Special Cash Dividend and Regular Quarterly Cash Dividend

Written by Customer Service on August 7, 2024. Posted in Dividend Reports And Estimates.

CHINO, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — Karat Packaging Inc. (Nasdaq: KRT) (the “Company” or “Karat”), a specialty distributor and manufacturer of disposable foodservice products and related items, today announced that its board of directors has approved payment of a regular quarterly cash dividend of $0.35 per share. The board also declared a special cash dividend of $0.15 per share on the Company’s common stock. Both dividends are payable on or about August 30, 2024, to shareholders of record at the close of business on August 21, 2024. “These distributions reflect Karat’s strong cash position and positive long-term outlook,” said Alan Yu, chief executive officer. “Our board remains committed to providing returns to our shareholders and to continually assess opportunities to enhance shareholder value.” About Karat Packaging...

OceanPal Inc. Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2024

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, Aug. 07, 2024 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today reported time charter revenues of $6.7 million, a net loss of $8.2 million and net loss attributed to common stockholders of $8.6 million for the second quarter of 2024. This compares to time charter revenues of $5.4 million, a net income of $1.3 million and net income attributed to common stockholders of $483 thousand for the second quarter of 2023. For the six months ended June 30, 2024, the Company reported time charter revenues of $12.4 million, a net loss of $9.5 million and net loss attributed to common stockholders of $10.3 million. This compares to time charter revenues of $9.3 million, a net income of $1.3 million and net income attributed to common stockholders...

Sprott Announces Second Quarter 2024 Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the three and six months ended June 30, 2024. Management commentary “We are pleased to report that during the second quarter of 2024, Sprott’s Assets Under Management (“AUM”) reached $31.1 billion, up 6% from March 31, 2024 and up 8% from December 31, 2023,” said Whitney George, CEO of Sprott. “After more than four years of positive net sales, we started 2024 with $284 million of net redemptions in the first quarter. This quarter, we returned to positive net sales with $357 million of net inflows and an additional $110 million from the recent initial public offering (“IPO”) of the Sprott Physical Copper Trust (“COP”), bringing our net sales in the first half of...

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

Written by Customer Service on August 7, 2024. Posted in Public Companies.

CAPLYTA Q2 2024 net product sales were $161.3 million, compared to $110.1 million for the same period in 2023, representing a 46% increase CAPLYTA’s strong prescription uptake continues: Q2 2024 CAPLYTA total prescriptions increased 36%, versus the same period in 2023 CAPLYTA 2024 net product sales guidance raised to $650 to $680 million Announced positive Phase 3 results from Study 501 and Study 502 evaluating lumateperone as an adjunctive therapy to antidepressants in patients with major depressive disorder (MDD) Supplemental NDA (sNDA) submission for lumateperone as an adjunctive therapy to antidepressants in patients with MDD anticipated in the second half of 2024 Commenced patient enrollment in ITI-1284 Phase 2 Studies in Generalized Anxiety Disorder and Psychosis associated with Alzheimer’s disease NEW YORK, Aug. 07, 2024 (GLOBE...

Month: August 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals